Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma

<div>The multivariate and univariate Cox regression analysis for the risk score in both training and validation cohort. Univariate Cox analysis for patients from (a) TCGA cohort and (b) GEO cohort. Multivariate Cox analysis for patients from (c) TCGA cohort and (d) GEO cohort.</div>

Disease Markers

fig5

Figure 5

Figure 5: Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma 

Figure 5 | Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma 